Passage Bio Inc (PASG)
1.32
+0.10
(+8.20%)
USD |
NASDAQ |
Apr 26, 16:00
1.32
0.00 (0.00%)
After-Hours: 18:03
Passage Bio Total Liabilities (Quarterly): 39.26M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.26M |
| September 30, 2023 | 42.98M |
| June 30, 2023 | 43.28M |
| March 31, 2023 | 42.89M |
| December 31, 2022 | 42.18M |
| September 30, 2022 | 45.66M |
| June 30, 2022 | 51.37M |
| March 31, 2022 | 51.91M |
| December 31, 2021 | 36.42M |
| Date | Value |
|---|---|
| September 30, 2021 | 28.71M |
| June 30, 2021 | 37.26M |
| March 31, 2021 | 23.67M |
| December 31, 2020 | 23.29M |
| September 30, 2020 | 19.79M |
| June 30, 2020 | 14.70M |
| March 31, 2020 | 5.761M |
| December 31, 2019 | 234.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.761M
Minimum
Mar 2020
234.87M
Maximum
Dec 2019
46.12M
Average
39.26M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 150.54M |
| Shareholders Equity (Quarterly) | 111.28M |